—
C+
C+ The full Closelook — membership. Open the C+ overview

Laboratory Corporation of America Holdings (LH) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Laboratory Corporation of America Holdings

LH in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Labcorp runs two main businesses: diagnostic laboratories that test blood, tissue and other samples for doctors and patients, and laboratory services that support drug developers running clinical trials. It offers routine tests such as blood counts and cholesterol panels alongside specialised work like genetic screening, cancer pathology and infectious-disease testing. Its clients include patients, physicians, health plans, government programmes and pharmaceutical and biotech companies. It is based in Burlington, United States, and has begun offering a generative-AI tool that helps clinicians choose the right test.
Where it sits in the stack
Labcorp sits outside our Rubin index, which tracks the AI hardware build-out; in our wider universe it belongs to the Healthcare sector, under diagnostics and research. Its work is processing patient and trial samples rather than supplying compute, chips or data-centre infrastructure, so it is not a constraint on or customer of that stack.
Who it is priced against
Closelook's peer group for Labcorp is not yet defined. The name the market most often compares it with is Quest Diagnostics, the other large commercial laboratory operator in the United States.
Why Closelook tracks it
Labcorp holds a seat in the S&P 500 but has no seat in Rubin or Halo, and its Closelook score has not yet been built. The diary has not yet quoted it in an edition.
What the diary watches
The diary watches how demand splits between routine diagnostic testing and the biopharma laboratory services tied to drug trials, and whether the new generative-AI test-selection tool changes how clinicians order tests.

Laboratory Corporation of America Holdings (LH) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for LH, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 2 analyst actions on the wire · latest: price target by UBS, 2026-09-11

The Street on this name

Analyst actions and the latest print for LH from the Closelook wires — third-party opinions on the record, not our readings.

  • Price target UBS — target 380 from 361 Target raised to $380 from $361 (+23.6% to spot) 2026-09-11
  • Price target Barclays — target 330 from 320 Target raised to $330 from $320 (+7.5% to spot) 2026-09-11

2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst wire → · Earnings wire →

Who it is priced against Diagnostics & Research · United States · 8 names with week and year-to-date

Peer group

Diagnostics & Research · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against LH on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 0.89%, quarterly · last 0.72 USD on 2026-08-28

Dividends and capital return

What LH pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.88 USD per share · a 0.89% yield on the 2026-09-17 close 4 distributions, paid quarterly 2026-09-17
  • Change on the year 0.0% against the prior twelve months prior twelve months 2.88 USD per share
  • Last distribution 0.72 USD per share as the price series records it, within days of the ex-date 2026-08-28
  • By calendar year 2023: 0.72 USD (partial) · 2024: 2.89 USD · 2025: 2.88 USD · 2026: 2.16 USD to date first distribution recorded in the three-year window: 2023-11-07

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Laboratory Corporation of America Holdings (LH)?

Laboratory Corporation of America Holdings trades as LH on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is LH in a Closelook index?

Not currently — Laboratory Corporation of America Holdings is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does LH trade against its moving averages?

Uptrend stack intact: Trades +3.3% vs the 50-day and +16.5% vs the 200-day average, 5.4% below the 52-week high and +33% off the 52-week low; a golden cross printed 42 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Laboratory Corporation of America Holdings do?

Labcorp runs two main businesses: diagnostic laboratories that test blood, tissue and other samples for doctors and patients, and laboratory services that support drug developers running clinical trials. It offers routine tests such as blood counts and cholesterol panels alongside specialised work like genetic screening, cancer pathology and infectious-disease testing. Its clients include patients, physicians, health plans, government programmes and pharmaceutical and biotech companies. Closelook's peer group for Labcorp is not yet defined. The name the market most often compares it with is Quest Diagnostics, the other large commercial laboratory operator in the United States.

Where does Laboratory Corporation of America Holdings sit in the AI build-out?

Labcorp sits outside our Rubin index, which tracks the AI hardware build-out; in our wider universe it belongs to the Healthcare sector, under diagnostics and research. Its work is processing patient and trial samples rather than supplying compute, chips or data-centre infrastructure, so it is not a constraint on or customer of that stack. Labcorp holds a seat in the S&P 500 but has no seat in Rubin or Halo, and its Closelook score has not yet been built. The diary has not yet quoted it in an edition.

Does Laboratory Corporation of America Holdings pay a dividend?

Laboratory Corporation of America Holdings has paid 2.88 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.89% on the 2026-09-17 close; the last distribution recorded in the price series was 0.72 USD on 2026-08-28. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Laboratory Corporation of America Holdings recently?

The most recent analyst action on Laboratory Corporation of America Holdings on the Closelook wire is a price target by UBS on 2026-09-11 (target 380 from 361). 2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for LH, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Diagnostics & Research. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.